LYMPHOCYTE DEACTIVATION BY (POTENTIAL IMMUNOSUPPRESSANT) ALKYLATING METABOLITES OF CYCLOPHOSPHAMIDE

被引:9
作者
WHITEHOUSE, MW
BECK, FWJ
DROGE, MM
STRUCK, RF
机构
[1] UNIV CALIF, SCH MED, DEPT MED, LOS ANGELES, CA 90024 USA
[2] SO RES INST, NAT PROD SECT, KETTERING MEYER LAB, BIRMINGHAM, AL 35205 USA
来源
AGENTS AND ACTIONS | 1974年 / 4卷 / 02期
关键词
D O I
10.1007/BF01966821
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
引用
收藏
页码:117 / 124
页数:8
相关论文
共 33 条
[21]  
SLADEK NE, 1973, CANCER RES, V33, P651
[22]  
STRUCK RF, 1971, MOL PHARMACOL, V7, P519
[23]  
STRUCK RF, UNPUBLISHED RESULTS
[24]   STUDIES ON CYCLOPHOSPHAMIDE METABOLITES AND THEIR RELATED COMPOUNDS .2. PREPARATION OF AN ACTIVE SPECIES OF CYCLOPHOSPHAMIDE AND SOME RELATED COMPOUNDS [J].
TAKAMIZA.A ;
MATSUMOT.S ;
IWATA, T ;
KATAGIRI, K ;
TOCHINO, Y ;
YAMAGUCH.K .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1973, 95 (03) :985-986
[25]  
TAKAMIZAWA A, 1972, CHEM PHARM BULL, V20, P1612
[26]  
UDENFRIEND S, 1954, J BIOL CHEM, V208, P731
[27]  
WHITEHOUSE MW, 1972, P W PHARMACOL SOC, V15, P195
[28]  
WHITEHOUSE MW, 1971, PHARMACOLOGIST, V13, P236
[29]   EFFECT OF CYCLOPHOSPHAMIDE ON A LOCAL GRAFT VERSUS HOST REACTION IN RAT - INFLUENCE OF SEX, DISEASE AND DIFFERENT DOSAGE REGIMENS [J].
WHITEHOUSE, MW ;
LEVY, L ;
BECK, FJ .
AGENTS AND ACTIONS, 1973, 3 (02) :53-60
[30]   SOME (PHARMACOLOGICAL) PROPERTIES OF CHLORACETALDEHYDE, AN OXIDATION-PRODUCT AND POTENTIAL METABOLITE OF CYCLOPHOSPHAMIDE [J].
WHITEHOUSE, MW ;
BECK, FJ ;
KACENA, A .
AGENTS AND ACTIONS, 1974, 4 (01) :34-43